In both RPCs and UCs, however, distant metastasis was closely associated with the presence of TERT promoter mutations: All 4 RPC patients with distant metastasis were mutation-positive whereas none of 56 patients with a wild-type TERT promoter had metastatic disease (P = 0.013, Fisher exact test, Table 1). Here, TERT is linked to metastatic neoplasm.